The pharmacogenomic assessment of molecular epithelial-mesenchymal transition signatures reveals drug susceptibilities in cancer cell lines
Alexander J. Ohnmacht(Helmholtz Zentrum München), Michael P. Menden(Biotechnology Institute)
Cited by 1
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
|PLoS ONE|2013|567
Transcriptional data: a new gateway to drug repositioning?
|Drug Discovery Today|2012|248
IL-9 sensitizes human TH2 cells to proinflammatory IL-18 signals in atopic dermatitis
|Journal of Allergy and Clinical Immunology|2024|16